Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (31-40 of 319) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Bisphosphonates for treatment and prevention of bone metastasesM Dror Michaelson, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Changes in PSA kinetics after DNA vaccine therapy-not so fast!Matthew R Smith, Philip W Kantoff
The American Journal of Clinical Nutrition|October 28, 2023
Do Global Dietary Nutrient Datasets Associate with Human Biomarker Assessments? A Regression AnalysisMatthew R Smith, Samuel S Myers
Investigational New Drugs|July 9, 2002
Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancerMatthew R Smith, Philip W Kantoff
Nature Reviews. Urology|October 7, 2009
Prostate cancer: How can we improve the health of men who receive ADT?Philip J Saylor, Matthew R Smith
The New England Journal of Medicine|August 17, 2012
Clinical decisions. Screening for prostate cancerAnthony V D'Amico, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
The Journal of Urology|March 17, 2009
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Current Oncology Reports|April 2, 2003
The role of bisphosphonates in the management of metastatic prostate cancerM Dror Michaelson, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Pageof 32

Showing results (31-40 of 319) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Bisphosphonates for treatment and prevention of bone metastasesM Dror Michaelson, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Changes in PSA kinetics after DNA vaccine therapy-not so fast!Matthew R Smith, Philip W Kantoff
The American Journal of Clinical Nutrition|October 28, 2023
Do Global Dietary Nutrient Datasets Associate with Human Biomarker Assessments? A Regression AnalysisMatthew R Smith, Samuel S Myers
Investigational New Drugs|July 9, 2002
Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancerMatthew R Smith, Philip W Kantoff
Nature Reviews. Urology|October 7, 2009
Prostate cancer: How can we improve the health of men who receive ADT?Philip J Saylor, Matthew R Smith
The New England Journal of Medicine|August 17, 2012
Clinical decisions. Screening for prostate cancerAnthony V D'Amico, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
The Journal of Urology|March 17, 2009
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Current Oncology Reports|April 2, 2003
The role of bisphosphonates in the management of metastatic prostate cancerM Dror Michaelson, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Pageof 32